Atlas Venture Fund XI Files Intent to Sell $1.4M in Korro Bio Stock
KRRO has more than doubled off its 52-week low of $5.204 on elevated volume (2.9× avg).
Summary
Atlas Venture Fund XI, a major shareholder, has filed to sell $1.41 million of Korro Bio stock, representing a notable reduction in its holdings and contributing to recent insider selling.
Key Events · Ownership and Investor Activity · KRRO
-
Intent to Sell Shares
Atlas Venture Fund XI, L.P. filed a Form 144 to sell 101,579 shares of Korro Bio common stock.
-
Significant Transaction Value
The proposed sale has an approximate market value of $1.41 million.
-
Institutional Shareholder Activity
The filer, Atlas Venture Fund XI, L.P., is a major institutional shareholder. Sales by such entities are often for portfolio rebalancing but can still impact market sentiment.
-
Part of Ongoing Distribution
This filing follows a pattern of recent Form 144 filings and contributes to a net distribution of shares by insiders over the last 90 days.
Analysis · KRRO · Life Sciences
Atlas Venture Fund XI, a significant institutional shareholder, has filed a Form 144 indicating its intent to sell approximately $1.41 million worth of Korro Bio common stock. This proposed sale represents about 0.7% of the company's market capitalization and adds to recent insider distribution activity. While institutional investors often rebalance portfolios, a sale of this magnitude from a major holder can create an overhang on the stock.
At the time of this filing, KRRO was trading at $13.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $197.7M. The 52-week trading range was $5.20 to $55.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.